PD Dr. Jörg Distler

Medizinische Fakultät Professur für Molekulare Mechanismen der Organfibrose

The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon? (2023) Distler J, Riemekasten G, Denton CP Journal article, Review article Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022) Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al. Journal article Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis (2022) Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, et al. Journal article Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153 (2022) Li YN, Chen CW, Trinh MT, Zhu H, Matei AE, Györfi AH, Kuwert F, et al. Journal article Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects (2022) Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler J, Alves M, Stock C, Distler O Journal article Autologous hematopoietic stem cell transplantation improves long-term survival-data from a national registry (2022) Blank N, Schmalzing M, Moinzadeh P, Oberste M, Siegert E, Mueller-Ladner U, Riemekasten G, et al. Journal article Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort (2022) Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, Cacciapaglia F, et al. Journal article Glucocorticoids prescribing practices in systemic sclerosis: an analysis of the EUSTAR database (2022) Iudici M, Mongin D, Siegert E, Carreira PE, Distler J, Henes J, Zanatta E, et al. Journal article Persistent inflammation in systemic sclerosis is strongly associated with mortality: a EUSTAR database analysis (2022) Guler SA, Sarbu A, Stadler O, Allanore Y, Bernardino , Distler J, Gabrielli A, et al. Conference contribution Blocking IL-1, IL-33 and IL-36 Signaling with the Anti-IL1RAP Antibody mCAN10 Ameliorates Inflammation and Fibrosis in Preclinical Models of Systemic Sclerosis (2022) Gronberg C, Rattik S, Kunz M, Thoung Trinh-Minh , TRAN MANH C, Zhou X, Skoog P, et al. Conference contribution